Developer docs
API playgroundTry for free, no card

Search company profiles

Corista

Full company profile

uuid000966m

Namestring
Corista
Legal namestring
Corista, LLC
Websiteurl
corista.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Corista is a privately held digital pathology software company founded in 2005 and headquartered in Concord, Massachusetts. The company develops and sells DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management platform that consolidates whole-slide images, gross images, and static pathology images into a unified case management and collaborative workflow suite. DP3 includes modules for clinical healthcare, life sciences research, education, analytics, conference/tumor board review, and reporting, all built on a proprietary middleware layer (the LIS Connector) that integrates with heterogeneous LIS, HIS, and EHR systems. The platform also features a patented Virtual Slide Stage ergonomic hardware device and is CE-marked under IVDR for diagnostic use in Europe and licensed by Health Canada, with 510(k) clearance in progress in the United States.

Corista sells DP3 through direct enterprise sales to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations, supplemented by strategic channel partnerships with scanner and imaging vendors including Evident (an Olympus subsidiary), Pramana, AGFA HealthCare, and Indica Labs. Revenue is generated through enterprise software licensing and subscriptions, complemented by implementation and integration professional services. The company targets enterprise customers including Dartmouth-Hitchcock Medical Center, Mayo Clinic, Massachusetts General Hospital, and unnamed multinational pharmaceutical/biotechnology firms. Corista is founder-led, with Elizabeth Wingard as Founder and CEO, and remains structured as a Massachusetts LLC, having filed an SEC Form D in December 2025 for an exempt securities offering of approximately $20 million to support growth and general corporate purposes.

Short descriptiontext

Corista provides DP3, a scanner-agnostic digital pathology image management and workflow platform, sold via enterprise subscriptions to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations for clinical, research, and education use.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersConcord, United States
HQ citystring
Concord
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pathology software, whole slide imaging, pathology workflow management, medical image management, healthcare IT solutions
Industry3 codes
PRIMARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAC
Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Custom Computer Programming Services541511
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Digital Pathology Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Software Licenses and Subscriptions
TypeSubscription Recurring
Description

DP3 is sold as a software platform to healthcare organizations and life sciences companies, likely through enterprise license or subscription arrangements. Pricing is not publicly disclosed and appears to be quote-based given the enterprise nature of sales.

corista.com
2Professional Services and Implementation
TypeProfessional Services
Description

Corista provides implementation and integration services for digital health systems, including deployment, configuration, and training as part of customer onboarding.

corista.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1DP3
Description

Digital Pathology Processing Platform - Corista's proprietary image management software platform for digital pathology workflows

corista.com
Core offering1 text field

Corista develops and sells the DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management software suite for pathology workflows. DP3 integrates whole-slide imaging, LIS/EHR connectivity, AI analytics, and real-time voice-enabled collaboration into a unified dashboard serving clinical, research, and education use cases at hospitals, medical centers, and life sciences companies. Corista also sells the patented Virtual Slide Stage (VSS) hardware device and provides implementation, integration, and training services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Turnaround time reduced from up to 2 weeks to as little as 1 hour for inter-institutional case reviews (Corista white paper, 'Crossing the Digital Divide')
+3 more records
Product overview1 text field

Corista offers the DP3 (Digital Pathology Processing Platform) as its core integrated digital pathology solution. DP3 is a comprehensive platform comprising multiple modules: Healthcare Module for clinical pathology workflows, Life Sciences Module for research applications, Research Module for project-based workflows, Education Module for teaching and training, Analytics Module for quantitative image analysis, Conference Module for multidisciplinary reviews, and Reports Module for QA insights. The platform includes a proprietary LIS Connector middleware for integration with laboratory and health information systems. Corista also offers the Virtual Slide Stage (VSS) hardware device for improved ergonomic digital slide viewing. All modules share the same image management foundation, supporting whole slide images, gross images, and static pathology images with voice collaboration and remote case review capabilities.

Product and service3 records
1DP3 (Digital Pathology Processing Platform)
CategoryDigital Pathology Software
Description

Integrated, scanner-agnostic digital pathology image management software that consolidates whole-slide images, gross images, static pathology images, and case metadata into a single dashboard for clinical, research, and education workflows at hospitals, medical centers, and life sciences organizations.

2Virtual Slide Stage (VSS)
CategoryPathology Hardware Device
Description

Patented desktop hardware interface device (about the size of a paperback book) that allows pathologists to view digital pathology slides using the same fine motor skills as traditional glass slide microscopy, easing adoption of digital workflows.

3LIS Connector Integration Engine
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-03-09
Description

Partnership combines Pramana's AI-enabled, high-throughput whole slide image scanning capabilities with Corista's DP3 platform to deliver fully automated, integrated digital pathology solutions for high-volume pathology laboratories. The collaboration builds a pathology-specific blueprint for clinical consult programs, global research networks, tissue archiving, and data lake assembly. Pramana is an AI-enabled health tech company headquartered in Cambridge, Mass., founded by nference, Inc.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-08-11
Description

Evident, a wholly-owned subsidiary of Olympus Corporation (formerly the Scientific Solutions division), partnered with Corista to extend digital pathology capabilities to its global customer base. Evident chose to partner with Corista in response to customer needs for expanded digital pathology capabilities. Corista's DP3 is the digital pathology software platform of choice for Evident's clients seeking advanced clinical, research, and educational capabilities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-02-11
Description

Integration between Corista's DP3 and Indica Labs' HALO quantitative image analytics platform provides pathologists instant access to deep tissue biomarker analysis directly within the DP3 workflow. The integration removes the need to build algorithms from scratch and enables archiving of results directly into DP3, with HALO's open API enabling scalable solutions.

4Dolbey
Strategic tierCoreTypeTechnology or Integration
Description

Corista partnered with Dolbey for speech recognition and workflow automation, integrated with Xifin LIS to deliver a completely hands-free, automated pathology workflow within the DP3 platform.

info.corista.com
5Xifin
Strategic tierCoreTypeTechnology or Integration
Description

Corista's LIS partner Xifin provides laboratory information system integration, enabling DP3 to connect with Xifin's LIS platform for fully automated, hands-free pathology workflow when combined with Dolbey speech recognition.

info.corista.com
Strategic tierCoreTypeTechnology or Integration
Description

Corista announced partnership with AGFA HealthCare to enhance digital pathology integration, enabling tighter interoperability between AGFA's enterprise imaging solutions and Corista's DP3 platform.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Corista partnered with Voicebook to transform pathology workflows through voice-enabled collaboration and documentation tools integrated into the DP3 platform.

8InteropKey
Strategic tierMinorTypeGTM or Marketing Partner
Description

Healthcare Innovators InteropKey and Corista joined forces to capture the expanding value-based care market through interoperability-focused go-to-market activities.

blog.corista.com
Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

EVIDENT (Evident), a wholly-owned subsidiary of Olympus Corporation, announced an alliance with Corista to automate digital pathology workflows, delivering integrated digital pathology solutions to clients worldwide.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Sectra offers enterprise imaging solutions including a digital pathology module integrated with its PACS/VNA platform. It competes with Corista on multi-vendor, vendor-neutral pathology image management, particularly in European health systems.

TypeEmerging player
Description

Ibex offers AI-driven cancer diagnostics with a dedicated workflow platform (Galen) for pathology. It is an emerging player targeting the same clinical pathology use cases as Corista's DP3, with a focus on integrated AI rather than vendor-neutral orchestration.

TypeDirect peer
Description

Pramana (founded by nference) provides AI-enabled high-throughput whole slide scanning and digital pathology workflow tools. It is both a Corista integration partner and a directly comparable vendor competing in image management for high-volume pathology labs.

TypeEmerging player
Description

PathAI develops AI-powered pathology diagnostics and operates its own AISight image management platform. It is an emerging player competing with Corista in the intersection of AI analytics and clinical workflow, particularly for biopharma and academic labs.

TypeBroad incumbent
Description

Hamamatsu provides NanoZoomer whole slide scanners and associated image management software. It is a broad incumbent in the digital pathology imaging space, with overlapping workflow tooling for clinical and research labs.

TypeBroad incumbent
Description

Philips offers IntelliSite Digital Pathology Solution, a fully integrated hardware-and-software platform competing directly with Corista's DP3 in clinical pathology workflows. As a global healthcare conglomerate, Philips is a broad incumbent with overlapping digital pathology capabilities.

TypeDirect peer
Description

Indica Labs provides HALO quantitative image analysis software for pathology and is an active integration partner of Corista. Its HALO platform overlaps with DP3's Analytics Module for biomarker analysis, making it a directly comparable vendor in the digital pathology workflow stack.

TypeEmerging player
Description

Qritive provides AI-powered pathology analysis integrated with workflow tools. It is an emerging player and a Corista partner (per DP3 integrations) competing in adjacent pathology AI use cases where Corista's AI-enabled modules are positioned.

TypeBroad incumbent
Description

Leica Biosystems (a Danaher company) offers Aperio digital pathology scanning and image management solutions. It competes head-to-head with Corista in scanner-centric pathology workflows, particularly for research and clinical use.

TypeBroad incumbent
Description

Roche's Ventana division offers integrated whole-slide imaging scanners and image management software for clinical pathology, directly competing with DP3. Roche is a broad incumbent leveraging its diagnostics franchise to bundle pathology workflow tools.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Corista

Digital Pathology Softwarecorista.com

Corista provides DP3, a scanner-agnostic digital pathology image management and workflow platform, sold via enterprise subscriptions to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations for clinical, research, and education use.

What Corista does

Corista is a privately held digital pathology software company founded in 2005 and headquartered in Concord, Massachusetts. The company develops and sells DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management platform that consolidates whole-slide images, gross images, and static pathology images into a unified case management and collaborative workflow suite. DP3 includes modules for clinical healthcare, life sciences research, education, analytics, conference/tumor board review, and reporting, all built on a proprietary middleware layer (the LIS Connector) that integrates with heterogeneous LIS, HIS, and EHR systems. The platform also features a patented Virtual Slide Stage ergonomic hardware device and is CE-marked under IVDR for diagnostic use in Europe and licensed by Health Canada, with 510(k) clearance in progress in the United States.

Corista sells DP3 through direct enterprise sales to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations, supplemented by strategic channel partnerships with scanner and imaging vendors including Evident (an Olympus subsidiary), Pramana, AGFA HealthCare, and Indica Labs. Revenue is generated through enterprise software licensing and subscriptions, complemented by implementation and integration professional services. The company targets enterprise customers including Dartmouth-Hitchcock Medical Center, Mayo Clinic, Massachusetts General Hospital, and unnamed multinational pharmaceutical/biotechnology firms. Corista is founder-led, with Elizabeth Wingard as Founder and CEO, and remains structured as a Massachusetts LLC, having filed an SEC Form D in December 2025 for an exempt securities offering of approximately $20 million to support growth and general corporate purposes.

Corista firmographics

Firmographics
Name
Corista
Legal name
Corista, LLC
Website
https://corista.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Corista provides DP3, a scanner-agnostic digital pathology image management and workflow platform, sold via enterprise subscriptions to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations for clinical, research, and education use.
Ownership category
akta.pro rank

Corista industry classification

Industry
Product category
Digital Pathology Software
NAICS
Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAC
Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Digital pathology software
  • Whole slide imaging
  • Pathology workflow management
  • Medical image management
  • Healthcare IT solutions

Where Corista is headquartered

Location

Headquarters

HQ city
Concord
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Corista business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Licenses and Subscriptions: DP3 is sold as a software platform to healthcare organizations and life sciences companies, likely through enterprise license or subscription arrangements. Pricing is not publicly disclosed and appears to be quote-based given the enterprise nature of sales.
  2. Professional Services and Implementation: Corista provides implementation and integration services for digital health systems, including deployment, configuration, and training as part of customer onboarding.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Corista product offering

Product offering

Core offering

Corista develops and sells the DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management software suite for pathology workflows. DP3 integrates whole-slide imaging, LIS/EHR connectivity, AI analytics, and real-time voice-enabled collaboration into a unified dashboard serving clinical, research, and education use cases at hospitals, medical centers, and life sciences companies. Corista also sells the patented Virtual Slide Stage (VSS) hardware device and provides implementation, integration, and training services.

Product overview

Corista offers the DP3 (Digital Pathology Processing Platform) as its core integrated digital pathology solution. DP3 is a comprehensive platform comprising multiple modules: Healthcare Module for clinical pathology workflows, Life Sciences Module for research applications, Research Module for project-based workflows, Education Module for teaching and training, Analytics Module for quantitative image analysis, Conference Module for multidisciplinary reviews, and Reports Module for QA insights. The platform includes a proprietary LIS Connector middleware for integration with laboratory and health information systems. Corista also offers the Virtual Slide Stage (VSS) hardware device for improved ergonomic digital slide viewing. All modules share the same image management foundation, supporting whole slide images, gross images, and static pathology images with voice collaboration and remote case review capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • DP3: Digital Pathology Processing Platform - Corista's proprietary image management software platform for digital pathology workflows

Products and services

  • DP3 (Digital Pathology Processing Platform) Integrated, scanner-agnostic digital pathology image management software that consolidates whole-slide images, gross images, static pathology images, and case metadata into a single dashboard for clinical, research, and education workflows at hospitals, medical centers, and life sciences organizations.
  • Virtual Slide Stage (VSS) Patented desktop hardware interface device (about the size of a paperback book) that allows pathologists to view digital pathology slides using the same fine motor skills as traditional glass slide microscopy, easing adoption of digital workflows.
  • LIS Connector Integration Engine

Quantifiable outcome

  • Turnaround time reduced from up to 2 weeks to as little as 1 hour for inter-institutional case reviews (Corista white paper, 'Crossing the Digital Divide')
  • +3 more outcomes

Companies that use Corista

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles3 records

Corista technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability4 records

Feature10 records

Corista partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

  • PramanaflagshipStrategic or Co-development Partner · 9 March 2023Partnership combines Pramana's AI-enabled, high-throughput whole slide image scanning capabilities with Corista's DP3 platform to deliver fully automated, integrated digital pathology solutions for high-volume pathology laboratories. The collaboration builds a pathology-specific blueprint for clinical consult programs, global research networks, tissue archiving, and data lake assembly. Pramana is an AI-enabled health tech company headquartered in Cambridge, Mass., founded by nference, Inc.
  • Evident (Olympus Corporation subsidiary)flagshipChannel Partner/ Reseller/ Distributor · 11 August 2022Evident, a wholly-owned subsidiary of Olympus Corporation (formerly the Scientific Solutions division), partnered with Corista to extend digital pathology capabilities to its global customer base. Evident chose to partner with Corista in response to customer needs for expanded digital pathology capabilities. Corista's DP3 is the digital pathology software platform of choice for Evident's clients seeking advanced clinical, research, and educational capabilities.
  • Indica LabscoreTechnology or Integration · 11 February 2020Integration between Corista's DP3 and Indica Labs' HALO quantitative image analytics platform provides pathologists instant access to deep tissue biomarker analysis directly within the DP3 workflow. The integration removes the need to build algorithms from scratch and enables archiving of results directly into DP3, with HALO's open API enabling scalable solutions.
  • DolbeycoreTechnology or IntegrationCorista partnered with Dolbey for speech recognition and workflow automation, integrated with Xifin LIS to deliver a completely hands-free, automated pathology workflow within the DP3 platform.
  • XifincoreTechnology or IntegrationCorista's LIS partner Xifin provides laboratory information system integration, enabling DP3 to connect with Xifin's LIS platform for fully automated, hands-free pathology workflow when combined with Dolbey speech recognition.
  • AGFA HealthCarecoreTechnology or IntegrationCorista announced partnership with AGFA HealthCare to enhance digital pathology integration, enabling tighter interoperability between AGFA's enterprise imaging solutions and Corista's DP3 platform.
  • VoicebookminorStrategic or Co-development PartnerCorista partnered with Voicebook to transform pathology workflows through voice-enabled collaboration and documentation tools integrated into the DP3 platform.
  • InteropKeyminorGTM or Marketing PartnerHealthcare Innovators InteropKey and Corista joined forces to capture the expanding value-based care market through interoperability-focused go-to-market activities.
  • EVIDENT (Olympus)flagshipChannel Partner/ Reseller/ DistributorEVIDENT (Evident), a wholly-owned subsidiary of Olympus Corporation, announced an alliance with Corista to automate digital pathology workflows, delivering integrated digital pathology solutions to clients worldwide.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Corista competitors and assessment

Company assessment

Broad incumbents

  • Sectra: Sectra offers enterprise imaging solutions including a digital pathology module integrated with its PACS/VNA platform. It competes with Corista on multi-vendor, vendor-neutral pathology image management, particularly in European health systems.
  • Hamamatsu Photonics (NanoZoomer): Hamamatsu provides NanoZoomer whole slide scanners and associated image management software. It is a broad incumbent in the digital pathology imaging space, with overlapping workflow tooling for clinical and research labs.
  • Philips (Philips IntelliSite Pathology Solution): Philips offers IntelliSite Digital Pathology Solution, a fully integrated hardware-and-software platform competing directly with Corista's DP3 in clinical pathology workflows. As a global healthcare conglomerate, Philips is a broad incumbent with overlapping digital pathology capabilities.
  • Leica Biosystems (Aperio): Leica Biosystems (a Danaher company) offers Aperio digital pathology scanning and image management solutions. It competes head-to-head with Corista in scanner-centric pathology workflows, particularly for research and clinical use.
  • Roche (Ventana Digital Pathology): Roche's Ventana division offers integrated whole-slide imaging scanners and image management software for clinical pathology, directly competing with DP3. Roche is a broad incumbent leveraging its diagnostics franchise to bundle pathology workflow tools.

Emerging players

  • Ibex Medical Analytics: Ibex offers AI-driven cancer diagnostics with a dedicated workflow platform (Galen) for pathology. It is an emerging player targeting the same clinical pathology use cases as Corista's DP3, with a focus on integrated AI rather than vendor-neutral orchestration.
  • PathAI: PathAI develops AI-powered pathology diagnostics and operates its own AISight image management platform. It is an emerging player competing with Corista in the intersection of AI analytics and clinical workflow, particularly for biopharma and academic labs.
  • Qritive: Qritive provides AI-powered pathology analysis integrated with workflow tools. It is an emerging player and a Corista partner (per DP3 integrations) competing in adjacent pathology AI use cases where Corista's AI-enabled modules are positioned.

Direct peers

  • Pramana: Pramana (founded by nference) provides AI-enabled high-throughput whole slide scanning and digital pathology workflow tools. It is both a Corista integration partner and a directly comparable vendor competing in image management for high-volume pathology labs.
  • Indica Labs: Indica Labs provides HALO quantitative image analysis software for pathology and is an active integration partner of Corista. Its HALO platform overlaps with DP3's Analytics Module for biomarker analysis, making it a directly comparable vendor in the digital pathology workflow stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Corista social profiles

Digital presence

Corista compliance and trust

Trust signal

Compliance6 records

Corista financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Corista leadership team

Management profile

Number of profiles

Profiles3 records

Corista funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Corista M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Corista

What does Corista do?

Corista develops and sells the DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management software suite for pathology workflows. DP3 integrates whole-slide imaging, LIS/EHR connectivity, AI analytics, and real-time voice-enabled collaboration into a unified dashboard serving clinical, research, and education use cases at hospitals, medical centers, and life sciences companies. Corista also sells the patented Virtual Slide Stage (VSS) hardware device and provides implementation, integration, and training services.

Is Corista a public or private company?

Corista is a private company. It is classified as venture growth investor backed and is currently operating.

When was Corista founded?

Corista was founded in 2005. It employs 11 to 50 people.

Where is Corista based?

Corista is headquartered in Concord, United States, in the North America region.

How does Corista make money?

Two revenue lines are on record. Software Licenses and Subscriptions are the primary driver. The others are professional Services and Implementation.

Who are Corista's main competitors?

Broad incumbents on record are Sectra, Hamamatsu Photonics (NanoZoomer), Philips (Philips IntelliSite Pathology Solution), Leica Biosystems (Aperio) and Roche (Ventana Digital Pathology). Emerging players are Ibex Medical Analytics, PathAI and Qritive. Direct peers are Pramana and Indica Labs.

Does Corista have an API?

No public API is recorded for Corista.

What industry is Corista in?

Corista's product category is Digital Pathology Software. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLACABAM, Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageCorista Completes 250 TB Legacy Slide Migration for Tier 1 Academic Medical Center, Laying the Foundation for an Enterprise Digital Pathology ProgramCorista completed a migration of roughly 250 terabytes of legacy slide data onto its DP3 platform for a California medical center with over 800 beds. The program supports 29 pathologists and 50 users, and the center has since added scanners and transitioned to Epic Beaker. It plans to expand its digital pathology network to two to three system hospitals by end of 2027.SecSEC FORM DCorista, LLC filed a Form D notice with the SEC on December 2, 2025, notifying regulators of an exempt offering of equity securities under Rule 506(b), with first sales dating back to March 1, 2023. The filing indicates a total offering amount of $20,080,000, of which $13,165,679 has already been sold to 77 investors, leaving $6,914,321 remaining. The company paid finder's fees of $381,780 to Trent Capital Management, Inc. in connection with the offering.PharmiWeb.comAGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in PathologyAGFA HealthCare announced the North American launch of Enterprise Imaging for Pathology, powered by Corista DP3, a digital pathology solution. The platform offers case management, data management, and streaming for large pathology files, with DP3 pursuing 510(k) clearance for US diagnostic use.MorningstarAGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in PathologyAGFA HealthCare announced the North American launch of Enterprise Imaging for Pathology, powered by Corista DP3, a digital pathology solution. The platform offers case management, streaming, and collaboration features, with DP3 pursuing 510(k) clearance for US diagnostic use.Business InsiderAGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in PathologyAGFA HealthCare announced the North American launch of Enterprise Imaging for Pathology, powered by Corista DP3, a digital pathology solution. The platform offers case management, streaming, and collaboration features, with DP3 pursuing 510(k) clearance for US diagnostic use.NasdaqAGFA HealthCare and Corista Announce North America Launch of its Integrated Solution for Digital Transformation in PathologyAGFA HealthCare and Corista announced the North America launch of Enterprise Imaging for Pathology, powered by Corista DP3. The solution offers pathology case management, data management, and streaming for large files, with DP3 pursuing 510(k) clearance for US diagnostic use.PR Newswire APACQritive and Corista Announce Partnership to Advance the Use of Computational Digital Pathology Workflows with Integrated Image ManagementQritive and Corista announced a partnership integrating Qritive's AI modules with Corista's DP3 image management platform. The combined solution screens for prostate and colon cancers, quantifies IHC markers, and detects lymph node metastasis. It aims to improve pathologist efficiency and support complex case review.PR NewswireOutlook on the Digital Pathology Global Market to 2027: Featuring 3Dhistech, Apollo Enterprise Imaging, Clinisys and Corista Among OthersResearch and Markets has added a new market report titled "Digital Pathology: Technologies and Global Markets" to its offerings, providing forecasts for the digital pathology sector through 2027. The report analyzes key market participants such as F. Hoffmann-La Roche Ltd. and Leica Biosystems Inc., alongside trends in AI integration and regulatory developments by bodies like the FDA. It covers global regional trends including North America, Europe, and Asia-Pacific, detailing market dynamics, competitive landscapes, and strategic investments.PrwebCorista Names Christopher Montoni VP of SalesCorista named Christopher Montoni Vice President of Sales to lead its sales and business development teams. Montoni, a 25-year medical imaging sales executive, previously served as Corista's Senior Director of Sales, where he increased worldwide opportunities. The role was created to lead growth from new partnerships and product development.